| Literature DB >> 34885846 |
Piotr Rosiak1, Ilona Latanska2, Paulina Paul1, Witold Sujka2, Beata Kolesinska1.
Abstract
Modified alginates have a wide range of applications, including in the manufacture of dressings and scaffolds used for regenerative medicine, in systems for selective drug delivery, and as hydrogel materials. This literature review discusses the methods used to modify alginates and obtain materials with new or improved functional properties. It discusses the diverse biological and functional activity of alginates. It presents methods of modification that utilize both natural and synthetic peptides, and describes their influence on the biological properties of the alginates. The success of functionalization depends on the reaction conditions being sufficient to guarantee the desired transformations and provide modified alginates with new desirable properties, but mild enough to prevent degradation of the alginates. This review is a literature description of efficient methods of alginate functionalization using biologically active ligands. Particular attention was paid to methods of alginate functionalization with peptides, because the combination of the properties of alginates and peptides leads to the obtaining of conjugates with properties resulting from both components as well as a completely new, different functionality.Entities:
Keywords: alginate peptide conjugates; carboxylic group transformations; degree of substitution (DS); diversified biological activity of alginates; hydrogelation; reactions of hydroxyl functions; regio- and chemoselectivity and specificity
Mesh:
Substances:
Year: 2021 PMID: 34885846 PMCID: PMC8659150 DOI: 10.3390/molecules26237264
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Structure of alginates: (a) conformation of the oligosaccharide chain; (b) distribution of M and G blocks in the polysaccharide chain.
Solubility of alginates in various solvents (c = 15 mg/mL).
| H2O | EG | DMAc | DMF | DMSO | DMAc | DMF /TBAF | DMSO /TBAF | DMAc /TBAF | DMI | |
|---|---|---|---|---|---|---|---|---|---|---|
| H-Alg | − | − | − | − | − | − | − | − | − | −- |
| Alg-Na | + | − | − | − | − | − | − | − | − | − |
| Alg-TBAF | + | + | − | − | − | - | + | + | + | + |
H-Alg—alginic acid; Alg-Na—sodium alginate; Alg-TBA—tetrabutylammonium alginate; EG—ethylene glycol; DMAc—N,N-dimethylacetamide; (+)—complete solubility; (−)—partially soluble or insoluble.
Figure 2Probable structure of the complex formed by binding of the Ca2+ ion with L-guluronic acid residues.
Figure 3P Possible structures of alginate chelates with Ca2+: (a) GG/GG, (b) MG/MG, (c) GG/MG.
Figure 4Acid-catalyzed degradation of alginic acid.
Figure 5Base catalyzed degradation of alginate (β-elimination).
Figure 6Acetylation of alginate using a mixture of pyridine/acetic anhydride. Gel acetylation: M = Ca2+ or TBA+. Acetylation of a homogeneous system in DMSO/TBAF, M = TBA+, M’= -H+ or Na+.
Substitution ratio of acetyl residues in blocks M and G.
| Origin of Alginate | DS | Acetylation (%) | |
|---|---|---|---|
| M | G | ||
|
| 0.1 | >90 | <10 |
|
| 0.4 | 80 | 20 |
|
| 0.4 | 3 | 36 |
DS value as a function of the alginate structure and acetylation reaction conditions.
| Substrate | DS (Homogeneous Reaction) | DS (Heterogeneous Reaction) |
|---|---|---|
| 100% M | 0.80 | 0.91 |
| 63% M | 0.80 | 0.48 |
| 29% M | 0.78 | 0.63 |
| 13% M | 0.78 | 0.54 |
| 0% M | 0.82 | 0.72 |
DS derived from 1H-NMR. Alginate TBA salts were used as the substrate at a concentration of 100 mg/mL. Under heterogeneous reaction conditions, the solvent was DMSO. Under homogeneous reaction conditions, the solvent was 100 mg TBAF/mL DMSO.
Figure 7Phosphorylation of alginates.
Figure 8Preparation of sulphate alginate derivatives using chlorosulfonic acid.
Figure 9Formation of sulphate alginate derivatives using DCC and sulfuric acid.
Figure 10T Formation of sulphate derivatives of alginates using a mixture of NaHSO3 and NaNO2.
Figure 11Oxidation of sodium alginate.
Figure 12Reductive amination of oxidized sodium alginate.
Figure 13Synthesis of PEG-ylated alginate derivative.
Examples of using the click chemistry reaction to obtain new alginate derivatives.
| Click Reaction | Functional Groups Involved in Reaction | Characteristic |
|---|---|---|
| Copper-(I)-Catalyzed Azide-Alkyne Cycloaddition | Azide–Alkyne | Cu-catalyzed (cytotoxic and difficult to remove from product) |
| Strain-Promoted | Azide–cyclic Alkyne | No catalyst needed |
| Inverse Electron Demand Diels–Alder Cycloaddition (IEDDA) | Dienophile–Diene | No catalyst needed |
| Diels–Alder | Diene–Alkene | No catalyst needed |
| Thiol-Ene Addition | Alkene–Thiol | Photoinitiator needed |
| Thiol-Michael Addition Click Reactions | Thiol–α,β-Unsaturated carbonyl compound | No catalyst needed |
| Thiol-Yne Addition | Alkyne–Thiol | Initiator needed |
| Oxime Coupling | Aminooxy compound–Aldehyde/Ketone | No catalyst needed |
Figure 14Esterification of alginates with alcohols.
Figure 15Activation of the carboxyl group using carbodiimide derivatives and subsequent reaction with nucleophilic reagents.
Figure 16Synthesis of alginic acid esters using alkyl halides.
Figure 17Synthesis of amides of alginates in the reaction of propylene glycol esters of alginates with amines.
Figure 18Formation of N-octylamide of alginic acid using EDC as a condensing agent.
Figure 19Ugi multi-component reaction for the preparation of amide alginate derivatives.
Figure 20Synthesis of alginate-peptide conjugate by alginate-S-S-y intermediate.
Summary of studies on the biological activity of alginate-peptide/protein conjugates.
| Peptide/Protein | Origin of Peptides | Bonding to Alginate | Material | Biological Impact | Ref. | |
|---|---|---|---|---|---|---|
| RGD | Fibronectin | Directly by EDC coupling | Printed hydrogel | Neuronal cells, increased neurite growth | [ | |
| Directly by EDC coupling | Hydrogel layer | Increased adhesion to the matrix | [ | |||
| 3D beads | Increased viability in a short time, lack of enhanced survival | |||||
| Directly by EDC coupling to methacrylate alginate | Hydrogel | Modified alginate promoted chondrocyte adhesion and spreading on the surface of the hydrogels | [ | |||
| Directly by EDC coupling on macroporous alginate scaffold | Hydrogel | Increased proliferation of MSCs in chondrogenic medium | [ | |||
| GGGGRGDY (RGD) | Directly by EDC coupling | Hydrogel | Increased cell attachment to the matrix, increased cell survival and recovery, inducing the organization of cardiac muscle tissue | [ | ||
| G6KRGDY (RGD) | Directly bonding self-assembling peptides by EDC coupling | Hydrogel | - | [ | ||
| A6KRGDY (RGD) | ||||||
| V6KRGDY (RGD) | ||||||
| GGGGRGEY | HCV E2 glycoprotein | Directly by EDC coupling | Solution | Less effective at attenuating scar expansion compared to unmodified alginate, similar myofibroblast infiltration into the scar compared to different biomaterial-treated infarcts | Lack of cardiofibroblast attachment to matrix | [ |
| GGGGRGDY/YIGSRYIGSRY (RGD/YIGSR) | Fibronectin/Laminin | Strong interaction of cardiofibroblast with the matrix | ||||
| YIGSR | Laminin | Directly by EDC coupling | Gel | Allowed adhesion of cells to the peptide-gel conjugate and promoted neurite outgrowth from the attached NB2a cells | [ | |
| YIGSR | Laminin | Directly by EDC coupling | Printed hydrogel | Neuronal cells, increased neurite growth | [ | |
| RGD-YIGSR | Fibronectin, | |||||
| GYIGSRG | Laminin | Directly via tetrabutyloamonium alginate salt, followed by 2-chloro- | Hydrogel | Induced angiogenesis 14 days after implantation and increased neovascular density almost 1.5 times in comparison to the control | [ | |
| AGTFALRGDNPQG | Laminin | Directly by EDC coupling | Matrice0073 | Promoted integrin avb3-mediated cell attachment and neurite outgrowth | [ | |
| RKRLQVQLSIRT | Promoted syndecan-mediated cell attachment, lower amounts of peptide-alginate showed strong neurite outgrowth activity decreasing with increasing amounts of peptide-alginate | |||||
| ATLQLQEGRLHFXFDLGKGR, X: Nle | Promoted strong cell attachment, promoted extensive cell spreading of human dermal fibroblasts | |||||
| ERRANAVRDVLVNEY | Outer membrane proteins of | Adipic acid dihydrazide as linker | - | Immunogenicity, | [ | |
| AGLGVGFNFGGSKAA | Outer membrane proteins of | Immunogenicity, | ||||
| Fmoc-FF-OH | Self-assembling peptide | Alginate-Fmoc-FF composite | Hydrogel | High biocompatibility confirmed with osteoblasts, properties similar to a natural extracellular matrix | [ | |
| LL-37 peptide | Native | Mixture | - | Reduced toxicity to mammalian cells while maintaining antibacterial properties | [ | |
| Tet213 | Modified | Directly by EDC coupling | ALG/HA/ COL-Tet213 3D-porous dressing | Improved antimicrobial activity, tested against MRSA, | [ | |
| EWGRRMMGWGRGRRMMRRWW (Ib-M6) | Ib-AMP4 | Peptide encapsulated in PVA-Alg pellets | Polyvinyl alcohol- alginate (PVA-Alg) matrix | Inhibited growth of microorganisms | [ | |
| GQGFSYPYKAVFSTQ sequence) | Bone forming peptide-1 | Peptide incorporated in the structure | Porous scaffold with incorporated peptide | Positive impact on cell adhesion, proliferation and aggregation towards MG-63 cells in vitro | [ | |
| GGGGGHKSP (GHK) | Native peptide analogue | Bonding to aldehyde group at oxidized alginate | Hydrogel | Increased proliferation and viability of the cells, ability to stimulate osteogenic differentiation of MSCs | [ | |
| Gelatin- GGGGGHKSP (gelatin-GHK) | Native protein-native peptide analogue | |||||
| REDV | Fibronectin | - | Hydrogel | Increased proliferation and enhanced angiogenesis | [ | |
| Ac-KSIRVAVAPG * | Hybrid peptide laminin/Elastin | Cross-linked by ethylenediamine fibrous calcium alginate with peptide directly bonded by EDC coupling | Fibrous | Induced cell attachment, effective promotion of granulation tissue regeneration and epithelialization | [ | |
| Ac-KSIRIAIAPG * | Lower activity than other peptides studied in this research | |||||
| Ac-KSIRIAIAPG * | Induced cell attachment, effective promotion of granulation tissue regeneration and epithelialization | |||||
| Ac-KSIRIGIGPG * | Slightly increased proliferation in comparison to control | |||||
| Ac-KSIKVAV (SIKVAV) * | Laminin | No significantly enhanced activity | ||||
| Ac-KVGVAPG (VGVAPG) * | Elastin | |||||
| Human serum albumin | Native | Hydrogel microspheres encapsulating a FITC-KRFK peptide coated with a human serum albumin-alginate membrane (HSA linked to ester groups of PGA by amide bonds) | Microspheres made of Ca2+ cross-linked PGA and alginate (2:1) | Surface membrane survived citrate treatment and lyophilization, no cytotoxicity against osteoblasts, slow release of the bioactive peptide from the core | [ | |
| Hydrogel microspheres encapsulating KRFK peptide coated with a human serum albumin-alginate membrane (HSA linked to ester groups of PGA by amide bonds) | Gel strength did not influence the amount of the peptide, the size of the microspheres did not influence affinity for the peptide biding sites, unlabeled KRFK peptide appeared to release significantly faster from microspheres, properties such as size, charge, and hydrophilicity impacted the time needed to release the peptide from the microspheres | [ | ||||
| c(RGD) | Fibronectin | Peptide bound to alginate via amide bond of heterobifunctional linkage, peptide connected via disulphide bond | Hydrogel | No cytotoxicity and increased ability to attach osteoblasts | [ | |
| FHRRIKA | Bone sialoprotein | No cytotoxicity | ||||
| KRSR | Fibronectin, vitronectin, bone sialoprotein, thrombospondin, osteopontin | |||||
| CGGREDV | Fibronectin | Multivalent surface – thiol modified alginate bonded with gold nanoparticles by Au-S bond, peptide bonded to gold particles on the surface of AuNPs | Hydrogel | Multivalent ligand maintained EC selectivity of the REDV peptide, compared with the monovalent ligand the REDV cluster showed superior EC adhesion capability, the | [ | |
| GREDV | Monovalent surface–peptide connected with alginate by amide bond | |||||
| Collagen originated peptides | Collagen | Directly by EDC coupling | - | Showed good hydrogen peroxide scavenging activity and promoted cell growth | [ | |
| Oligoproline derivatives | PPI/PPII helical structure | Directly by DMT/NMM/TosO- | Calcium alginate nonwoven modified with oligoproline derivatives | No cytotoxicity | [ | |
| Gelatin | Native | Hydrogel loaded with microbeads of blended gelatin-pectin | Hydrogel loaded with microbeads | Enhanced stem cell function and osteogenic differentiation capability | [ | |
| Gelatin methacrylate RGD | Gelatin | Alginate-RGD hydrogel with encapsulated gingival mesenchymal stem cells | Hydrogel | Accelerated wound closure and healing without infection | [ | |
| Interleukin-4 | Native | Hydrogel complexed with alginate-chitosan microspheres loaded with interleukin-4 and endothelial progenitor cells (EPCs) and RAW264.7 | Hydrogel loaded with microbeads | Promotes microvascularization | [ | |
| Gelatin methacryloyl | Gelatin | Alginate/Gelatin methacryloyl hydrogel loaded with hydroxyapatite | Hydrogel | Enable cell proliferation, spreading and adhesion. Promote the osteogenic differentiation of MC3T3- E1 cells | [ | |
| Vascular endothelial growth factor (VEGF), | Native | VEGF and D+PDGF nanoparticles encapsulated in calcium alginate hydrogel | Hydrogel loaded with | Improvement of vascularization and vascular maturity in testicular tissue grafts | [ | |
| Fibrin | Native | Fibrin/alginate scaffold with incorporated calcium phosphate deposits | Foam | Biocompatible and proangiogenic | [ | |
| Collagen | Native | Alginate/collagen hydrogel bead containing lapidated tissue factor | Hydrogel beads | Hemostatic activity, undetectable cytotoxicity | [ | |
| Laminin | Native | Mixed oxidized alginate-gelatin-laminin hydrogel | Hydrogel | Increase in neuronal differentiation in comparison to oxidized alginate-gelatin, with enhanced neuron migration from the neurospheres to the bulk 3D hydrogel matrix | [ | |
* Each of these peptides independently promoted proliferation.